Pearl River Capital, LLC - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 187 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.

Quarter-by-quarter ownership
Pearl River Capital, LLC ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$389,000
-2.5%
7,527
-18.2%
0.12%
-13.3%
Q4 2020$399,000
+41.5%
9,204
+14.4%
0.14%
+21.2%
Q3 2020$282,000
+781.2%
8,048
+778.6%
0.12%
+90.3%
Q1 2020$32,0009160.06%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
BB BIOTECH AG 2,719,998$155,502,0004.38%
Casdin Capital, LLC 295,000$16,865,0004.11%
Opaleye Management Inc. 130,000$7,432,0002.38%
Opus Point Partners Management, LLC 28,704$1,641,0001.42%
Fernwood Investment Management, LLC 27,550$1,575,0000.84%
Rhenman & Partners Asset Management AB 100,000$5,717,0000.77%
COLUMBIA WANGER ASSET MANAGEMENT LLC 760,116$43,456,0000.65%
Eventide Asset Management 214,000$12,234,0000.64%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 262,984$15,035,0000.59%
CAPITAL GUARDIAN TRUST CO 663,089$37,909,0000.54%
View complete list of AGIOS PHARMACEUTICALS INC shareholders